PTK2 and head and neck squamous cell carcinoma: Recent findings provide evidence for an essential role of ILK for EGFR targeting in HNSCC [113] and that EGFR overexpression mediates hypersusceptibility to the anti-EGFR antibody cetuximab in 3D grown HNSCC cell lines in a FAK-dependent manner [55].